Kymera Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. MU
6. FDX
7. IBM
8. PRIM
9. PFE
10. AWK

Go back to Kymera Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Business Update

Kymera Therapeutics (KYMR) Misses Q2 EPS by 8c

August 9, 2022 7:50 AM EDT

Kymera Therapeutics (NASDAQ: KYMR) reported Q2 EPS of ($0.78), $0.08 worse than the analyst estimate of ($0.70). Revenue for the quarter came in at $11.51 million versus the consensus estimate of $13.84 million.

For earnings history and earnings-related data on Kymera Therapeutics (KYMR) click here.

... More